Health Union Launches First-of-Its-Kind People-based Data Engine
ILLUMINÉ™ Harnesses the Power of Community to Build Privacy-first, Persona-Based Media Solutions PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- Health Union,...
Pharmaceutical
Segmed Secures $10.4 Million Series A Funding, Led by iGan Partners and Advocate Health
The investment is a pivotal milestone allowing Segmed to further expand its medical imaging solutions for artificial intelligence development and...
IDBS is proud to announce the renewal of its ISO 9001 and ISO 27001 certificates
WOKING, England, Sept. 3, 2024 /PRNewswire/ -- IDBS, a provider of cloud software for BioPharma companies, is pleased to announce...
PhaseV to Present at Upcoming Healthcare, Pharma and Technology Events
New Research and Case Studies Demonstrate Effectiveness of Machine Learning-Based Platforms for Adaptive Clinical Trial Design and Analysis BOSTON, Sept....
IntegriChain Appoints Tim Murdoch as Chief Commercial Officer to Drive Continued Growth and Customer Value
PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- IntegriChain, the leading provider of revenue optimization technology and insights for the pharmaceutical industry,...
Humonix Bio Announces Appointment of Thurein Htoo as Chairman of the Board of Directors and Welcomes Christie Markowitz as New Independent Board Director
ALBANY, NY / ACCESSWIRE / September 3, 2024 / Humonix Biosciences, Inc., a leading specialty pharmaceutical research company, is pleased...
Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval...
Y-mAbs to Participate in Upcoming Investor Conferences in September
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical...
Avenue Therapeutics to Participate in Upcoming Investor Conferences
MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
Better Choice Company Signs Definitive Agreement to Acquire SRx Health for Approximately $125 Million
Combined company will emerge as a leading global health and wellness company by providing products and solutions for families to...
QL Biopharm Announces Abstract on Novel Ultra Long-acting GLP-1RA to be Presented at EASD Annual Meeting 2024
– Abstract on data from a two-part phase 1c, multiple ascending dose study accepted for oral presentation – – New...
iZafe Group Introduces a Groundbreaking Tripartite Collaboration Aimed at Enhancing Independence and Safety in Medical Care
STOCKHOLM, SWEDEN / ACCESSWIRE / September 3, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB ("iZafe Group") today announces a...
Evotec Announces Change in Management Board
Dr Matthias Evers steps down as Chief Business Officer effective 01 October 2024Distribution of responsibilities across other Management Board functions...
Health Kiosk Market Surges to USD 3.29 Billion by 2030, Propelled by 12.17% CAGR – Verified Market Reports®
The global Health Kiosk Market is driven by a combination of technological advancements, increasing healthcare awareness, and the rising demand...
Referral Management Market is expected to generate a revenue of USD 13.48 Billion by 2031, Globally, at 15.8% CAGR: Verified Market Research®
The Referral Management Market is driven by the increasing demand for coordinated patient care, the rising adoption of digital healthcare...
Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor
NANJING, China, Sept. 2, 2024 /PRNewswire/ -- On September 02, 2024, Simcere Zaiming, an innovative oncology company under Simcere Pharmaceutical Group...
Hemogenyx Pharmaceuticals PLC Announces CDX Development Update
CDX Development Update LONDON, UNITED KINGDOM / ACCESSWIRE / September 2, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO)("Hemogenyx Pharmaceuticals" or the...
Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024
GENEVA, SWITZERLAND / ACCESSWIRE / September 2, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical...
Cosmo Pharmaceuticals Highlights Study Published in “The Lancet” Demonstrating the Efficacy of GI Genius(TM) in Colonoscopy Procedures
Dublin, Ireland--(Newsfile Corp. - September 2, 2024) - Cosmo Intelligent Medical Devices (Cosmo IMD), a division of Cosmo Pharmaceuticals N.V....
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest...